178 related articles for article (PubMed ID: 19188665)
1. EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion.
Ziegler A; Heidenreich R; Braumüller H; Wolburg H; Weidemann S; Mocikat R; Röcken M
Blood; 2009 Apr; 113(15):3494-502. PubMed ID: 19188665
[TBL] [Abstract][Full Text] [Related]
2. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
[TBL] [Abstract][Full Text] [Related]
3. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.
Barnard A; Mahon BP; Watkins J; Redhead K; Mills KH
Immunology; 1996 Mar; 87(3):372-80. PubMed ID: 8778021
[TBL] [Abstract][Full Text] [Related]
4. Co-development of naive CD4+ cells towards T helper type 1 or T helper type 2 cells induced by a combination of IL-12 and IL-4.
Palm N; Germann T; Goedert S; Hoehn P; Koelsch S; Rüde E; Schmitt E
Immunobiology; 1996-1997; 196(5):475-84. PubMed ID: 9145325
[TBL] [Abstract][Full Text] [Related]
5. Limited ability of antigen-specific Th1 responses to inhibit Th2 cell development in vivo.
Yasumi T; Katamura K; Okafuji I; Yoshioka T; Meguro TA; Nishikomori R; Kusunoki T; Heike T; Nakahata T
J Immunol; 2005 Feb; 174(3):1325-31. PubMed ID: 15661889
[TBL] [Abstract][Full Text] [Related]
6. Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.
Kyte JA; Trachsel S; Risberg B; thor Straten P; Lislerud K; Gaudernack G
Cancer Immunol Immunother; 2009 Oct; 58(10):1609-26. PubMed ID: 19221745
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation.
Foucras G; Coudert JD; Coureau C; Guéry JC
J Immunol; 2000 Nov; 165(9):4994-5003. PubMed ID: 11046027
[TBL] [Abstract][Full Text] [Related]
8. Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructs.
Kufer P; Zettl F; Borschert K; Lutterbüse R; Kischel R; Riethmüller G
Cancer Immun; 2001 Nov; 1():10. PubMed ID: 12747771
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression.
Rodriguez-Galán MC; Bream JH; Farr A; Young HA
J Immunol; 2005 Mar; 174(5):2796-804. PubMed ID: 15728489
[TBL] [Abstract][Full Text] [Related]
10. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
[TBL] [Abstract][Full Text] [Related]
11. Transfer of IFNgamma-depleted CD4(+) T cells together with CD8(+) T cells leads to rejection of murine kidney sarcoma in mice.
Klugewitz K; Scheffold A; Radbruch A; Hamann A
Int J Cancer; 2000 Sep; 87(5):673-9. PubMed ID: 10925361
[TBL] [Abstract][Full Text] [Related]
12. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
Schweitzer AN; Sharpe AH
J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
[TBL] [Abstract][Full Text] [Related]
13. CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen.
Rogers PR; Croft M
J Immunol; 2000 Mar; 164(6):2955-63. PubMed ID: 10706682
[TBL] [Abstract][Full Text] [Related]
14. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
Wang X; Mosmann T
J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
[TBL] [Abstract][Full Text] [Related]
15. IL-4 exacerbates disease in a Th1 cell transfer model of colitis.
Fort M; Lesley R; Davidson N; Menon S; Brombacher F; Leach M; Rennick D
J Immunol; 2001 Feb; 166(4):2793-800. PubMed ID: 11160346
[TBL] [Abstract][Full Text] [Related]
16. Altered Th1 cell differentiation programming by CIITA deficiency.
Patel DR; Kaplan MH; Chang CH
J Immunol; 2004 Nov; 173(9):5501-8. PubMed ID: 15494498
[TBL] [Abstract][Full Text] [Related]
17. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
Tao X; Constant S; Jorritsma P; Bottomly K
J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin (IL)-18 receptor alpha chain expression on CD4(+) T cells during T helper (Th)1/Th2 differentiation. Critical downregulatory role of IL-4.
Smeltz RB; Chen J; Hu-Li J; Shevach EM
J Exp Med; 2001 Jul; 194(2):143-53. PubMed ID: 11457889
[TBL] [Abstract][Full Text] [Related]
19. Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.
Kao JY; Zhang M; Chen CM; Pierzchala A; Chen JJ
Immunol Lett; 2006 May; 105(1):16-25. PubMed ID: 16388858
[TBL] [Abstract][Full Text] [Related]
20. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
DiIulio NA; Xu H; Fairchild RL
Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
